Lifecare ASA

Report Publication Announcement • May 9, 2025

LIFECARE ASA (LIFE): INVITATION TO PRESENTATION OF Q1 2025 RESULTS AND STRATEGIC UPDATE

Lifecare ASA will release its results for the first quarter of 2025 on Thursday, 15 May 2025 at 07:00 a.m. CEST. The company will host a presentation of the results and provide a strategic update on the path to commercialization at 10:00 a.m. the same day.

Lifecare ASA hereby invites you to the presentation of the first quarter 2025 results, including a strategic update on the path to commercialization.

Venue: Hotel Continental, Stortingsgaten 24/26, 0117 Oslo, Norway. Date: Thursday 15 May Time: 10:00 a.m. CEST

The results will be presented in English and broadcast live via webcast, followed by a Q&A session. Participants will be able to submit questions online throughout the session.

To access the webcast Join the Teams-meeting here.

A recording of the webcast will be available on our website immediately after the event.

Following the presentation, Lifecare invites participants to 1:1 meetings with CEO Joacim Holter and CFO Renete Kaarvik.

To register for physical attendance and to schedule a 1:1 meeting, please contact: kristin. samuelsen@dnb.no.

About us

Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring ("CGM") systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42